InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Bazemore Robert B. Director active across 2 companies, notably Akari Therapeutics Plc. Cumulatively, 3 disclosures have been recorded. Activity tracked since 6 March 2025. The latest transaction was filed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations